The newly discovered uncoupling protein-2 (UCP2) has been proposed to play a critical role in thermoregulatory and substrate oxidation processes. Skeletal muscle mRNA expression and, more recently, the protein content of UCP2 were investigated in humans. These studies have shown that the content of this protein varies quite substantially and that several factors could be responsible for its variation in human skeletal muscle. The aim of this review is to determine whether obesity and low-intensity increased contractile activity contribute to variation in muscle UCP2 content. A recent study from our laboratories revealed that, in obesity, UCP2 content in skeletal muscle is overexpressed by about 1.5-fold compared to lean. Body weight loss in obese subjects did not cause any change in skeletal muscle UCP2 content. On the other hand, when increased muscular contractile activity of knee extensor muscles is induced by several weeks of low-frequency electrical stimulation, UCP2 content increased by about 15%. Obesity and increased contractile activity do not appear suf®cient, however, to explain the magnitude of the human skeletal muscle variation in UCP2 content. Since intensive efforts are being devoted to this area of research, it is expected that our understanding of the causes contributing to its variation in humans will soon be substantially improved.
Introduction
More than 15 years ago, the gene encoding a mitochondrial uncoupling protein (UCP) expressed exclusively in brown adipose tissue (BAT) was cloned. 1, 2 This protein was shown to be a key player in nonshivering thermogenesis in rodents, 3 ± 5 and its overexpression in rodents had major metabolic consequences since it prevented the occurrence of genetic obesity. 6 Human variation in the content of UCP1 (as it is now called) was not expected to play a major role in the pathogenesis and treatment of human obesity since BAT, where it is exclusively found, accounts for a very small fraction of total body weight in adults. Recently, homologues of the BAT UCP1 have been identi®ed 7 ± 12 and proposed as proteins that could provide new clues to the causes of obesity. 13, 14 UCP2, which has 59% homology to UCP1, is expressed in different tissues including skeletal muscle. 15 It is known that muscle contributes substantially to the interindividual differences in energy expenditure 16 and to the selective utilization of substrates under resting or stimulated conditions. 17 It is now evident that mRNA expression 18, 19 and protein content 20, 21 of UCP2 in skeletal muscle varies among individuals. Recent reviews of the literature 15, 22 demonstrate that several factors can modulate the level of UCP2 mRNA expression in skeletal muscle, although most studies were undertaken in small mammals. The present review has the purpose to summarize our knowledge of the effects of obesity and body weight loss, and of increased contractile activity on the protein content of UCP2 in human skeletal muscle.
Quanti®cation of UCP2 content in human skeletal muscle
After the DNA sequence was determined, 7 our goal was to develop an UCP2 antibody that could allow investigations on the protein content of different tissues exposed to different environmental conditions. An af®nity puri®ed antibody raised against the 15 amino acids at the C-terminus of human UCP2 was produced and its speci®city was demonstrated. 20 As shown in Figure 1 , a single major band is observed with the use of a chemiluminescence-coupled goatanti-rabbit IgG antibody and corresponds to the expected molecular weight of UCP2 (that is about 32 kDa). In our laboratory, measurements of UCP2 in muscle is done from homogenates of vastus lateralis muscle samples obtained with the use of the needle biopsy technique. Small pieces of the muscle samples (about 10 mg) are homogenized in a glass ± glass Duall homogenizer with 40 vol of homogenization buffer (Na-K-PO 4 100 mM, EDTA 2 mM, pH 7.2) and sonicated six times for 5 s at 20 watts, with pauses of 85 s between pulses. Standardized amounts of total protein (determined with the Biorad assay kit) are blotted on a membrane and immunoblots are scanned. The intensity of each blot is analyzed with the use of NIH Image software. All individual values are expressed as arbitrary units of UCP2 per g of wet weight muscle (AUag). The homogenates are also used for the determination of cytochrome c oxidase enzyme activity (expressed in micromoles of substrate per minute per gram of wet weight tissue or Uag), an enzyme localized within the inner mitochondrial membrane, with the use of a well established spectrophotometric technique. 23 
Variation in the protein content of UCP2 in skeletal muscle
The data presented in Figure 2 show the important differences in protein content of UCP2 in skeletal muscle of 220 different human samples. These data reveal that UCP2 content is normally distributed and that there is at least a 6-fold difference between the lowest and highest values measured in these sedentary and physically active (but not highly trained) subjects. In agreement with a recent review, 15 this distribution clearly suggests that several factors (of genetic and non-genetic origin) are most likely contributing to this variation in human skeletal muscle.
Obesity and UCP2 content in skeletal muscle
To test the hypothesis that skeletal muscle UCP2 content may contribute to obesity, muscle biopsies were obtained from 18 obese non-diabetic (Ob; 35 AE 7% body fat) and lean individuals (L; 19 AE 5% body fat) for the measurements of cytochrome c oxidase (COX) enzyme activity and UCP2 protein content. 20 While a lower muscle COX activity was found in the Ob compared to L (6.9AE 1.6 vs 9.6 AE 1.2 Uag; P`0.001), skeletal muscle UCP2 content in Ob was signi®cantly higher than in L (48 AE 9 vs 33 AE 12 AUag; P`0.05). To verify whether there was a disproportionate expression of UCP2 content and COX, the ratio of UCP2 to COX activity was determined for each subject. This ratio revealed that the expression of UCP2 compared to COX was 2-fold higher in Ob than in L individuals (7.1 AE 1.6 vs 3.6 AE 1.6; P`0.01; Figure 3) . Moreover, the UCP2aCOX ratio was positively and signi®cantly related to the percentage of total body fat (r 0.63, P`0.05). These results suggest that UCP2 content in skeletal muscle appears to be involved in the pathophysiology of obesity in humans, and that obesity is a Figure 1 Different amounts of muscle proteins (5, 10 and 15 mg) were separated on a polyacrylamide gel, transferred to a nylon membrane, and immunoblotted with af®nity puri®ed antibody raised against the 15 amino acids at the C-terminus of human UCP2. The antibody ± antigen complex was visualized with the use of a chemiluminescence-coupled goat-anti-rabbit IgG antibody. Figure 2 Inter-individual variation in protein content of UCP2 in human skeletal muscle (AUag). The number of muscle samples analysed was 220.
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Body weight loss in obese subjects and UCP2 content in skeletal muscle
It is well known that caloric restriction can alter several physiological parameters of the human body, and one of our goals was to verify whether the protein content of UCP2 in skeletal muscle of obese individuals can be modi®ed after body weight loss. To test this hypothesis, measurements of cytochrome c oxidase (COX) enzyme activity and of the protein content of UCP2 were done in biopsies taken before and following a 4-month dietary and behavioral weight loss (WL) program 24 from the vastus lateralis muscle of 24 obese glucose-tolerant individuals. 25 The skeletal muscle UCP2 content remained unaltered (40AE 8 vs 42 AE 10 AUag; P 0.39) while muscle COX activity (7.3 AE 1.7 vs 6.4 AE 1.4 Uag; P`0.01) signi®cantly decreased after weight loss. These results suggest that UCP2 content in skeletal muscle is not primarily involved in the adaptive processes of energy conservation induced by caloric restriction in obese individuals. 26 Moreover, it seems that body weight loss, at least in obese individuals, is not likely contributing to the inter-individual variation in skeletal muscle UCP2 protein content.
Increased contractile activity and UCP2 content in skeletal muscle
Chronically increased muscular contractile activity is known to modify several metabolic aspects of skeletal muscle. 27 To test the hypothesis that changes in muscular contractile activity could alter the protein content of UCP2 in human skeletal muscle, knee extensor muscles of 31 healthy and sedentary subjects were submitted to 3 h per day of transcutaneous neuromuscular low-frequency electrical stimulation (LFES), 6 days per week for 6 weeks, as described previously. 28 Sessions of continuous 8 Hz electrical stimulation were performed during 90 min in the morning and 90 min in the evening. Vastus lateralis muscle biopsies were obtained before and at the end of the protocol for the determination of UCP2 and COX enzyme activity. Both the skeletal muscle UCP2 content (29AE 7 vs 33 AE 7 AUag; P 0.01) and COX activity (8.8AE 1.7 vs 10.7 AE 1.7 Uag; P`0.001; Figure 4 ) increased in response to the stimulation protocol. The UCP2aCOX ratio revealed, however, that the expression of UCP2 compared to COX was slightly, but not signi®cantly, decreased (3.4 AE 1.1 vs 3.2 AE 1.1; ns). These results indicate that although the protein content of UCP2 increased, this increase appears to be most likely attributed to a stimulationinduced rise in mitochondrial content. Under these conditions, an increased potential for uncoupling between oxidative phosphorylation and respiration is unlikely; this uncoupling has been recognized, at least in brown adipose tissue, 3 to favour an excess of heat production under stimulating conditions. It seems clear, however, that increased contractile activity is among the factors causing variations in the skeletal muscle protein content of UCP2 in humans.
Summary
The data presented in this paper clearly reveal that the protein content of UCP2 in human skeletal muscle is quite variable and that several factors are most likely contributing to this variability. As depicted in Figure  5 , our results demonstrate that obesity and increased muscular contractile activity are among the factors responsible for a signi®cant proportion of the variation in protein content of UCP2 in human skeletal muscle. 
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J-A Simoneau et al S70 Figure 5 Summary of the effects of obesity, body weight loss, and increased contractile activity on the protein content of UCP2, and on the UCP2aCOX ratio of skeletal muscle in humans. L: lean; STIM: post-stimulation; Ob: Obese; BWL: after body weight loss.
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